Results 51 to 60 of about 19,884 (196)

Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants [PDF]

open access: yes, 2011
Adrenocortical carcinoma (ACC) is a rare, heterogeneous malignancy with a poor prognosis. According to WHO classification 2004, ACC variants include oncocytic ACCs, myxoid ACCs and ACCs with sarcomatous areas. Herein, we provide a comprehensive review of
Ronald R. de Krijger   +1 more
core   +1 more source

EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity

open access: yesDiscover Oncology, 2022
Adrenocortical carcinoma affects one in 5 million children each year. Since prognosis for children older than 4 years is limited, clinicians often choose aggressive treatment with etoposide, doxorubicin, cisplatin (EDP) and mitotane after resection ...
Rebecca V. Steenaard   +4 more
doaj   +1 more source

Adrenocortical carcinoma: A rare tumor in a 12-year-old girl

open access: yesIndian Journal of Medical and Paediatric Oncology, 2018
A 12-year-old girl presented with intra-abdominal mass and cushingoid features. On investigation, she was diagnosed as a case of functioning adrenocortical carcinoma.
Sandesh V Parelkar   +8 more
doaj   +1 more source

Venous Tumor Thrombosis and Pulmonary Metastases in a Case of Adrenal Neuroblastoma—Occurrence of Two Rare Manifestations in a Single Patient: Case Report and Review of Literature

open access: yesJournal of Gastrointestinal and Abdominal Radiology, 2020
Unlike other pediatric extra cranial solid neoplasms, neuroblastomas have very low incidence of pulmonary metastases. Neuroblastomas also tend to encase rather than infiltrate the major vessels with very low incidence of tumor thrombus.
Somesh Singh   +5 more
doaj   +1 more source

Rare pediatric malignancies - A twenty year experience from an oncology institute in South India

open access: yesPediatric Hematology Oncology Journal, 2021
Background: Rare pediatric malignancies, as the name suggests, are not very frequently encountered in day to day practice. The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) defines a rare childhood cancer as one that has an ...
Aarthi Viswanathan   +6 more
doaj   +1 more source

Low-dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2022
Mitotane is an adrenolytic drug that exhibits therapeutic effects within a narrow target range (14–20 μg/dL). Various complications develop if the upper limit is exceeded.
You Joung Heo   +9 more
doaj   +1 more source

Role of the mTOR pathway in normal and tumoral adrenal cells [PDF]

open access: yes, 2010
The mammalian target of rapamycin (mTOR) is a kinase of the phosphoinositide 3-kinase (PI3Ks)/protein kinase B (PKB or AKT) signaling pathway, which is one of the most important intracellular mediators of the activity of growth factors receptors ...
Hofland, L.J. (Leo)   +3 more
core   +1 more source

Association of the germline R337H mutation with breast cancer in southern Brazil [PDF]

open access: yes, 2008
Background The germline TP53-R337H mutation is strongly associated with pediatric adrenocortical tumors (ACT) in southern Brazil; it has low penetrance and limited tissue specificity in most families and therefore is not associated with Li-Fraumeni ...
Srivastava Kumar   +12 more
core   +2 more sources

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022

open access: yesThe Journal of Dermatology, Volume 53, Issue 5, Page e257-e356, May 2026.
ABSTRACT The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita   +116 more
wiley   +2 more sources

New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells

open access: yesClinics
OBJECTIVES: Transcription Factor 21 represses steroidogenic factor 1, a nuclear receptor required for gonadal development, sex determination and the regulation of adrenogonadal steroidogenesis.
Monica Malheiros França   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy